203 related articles for article (PubMed ID: 35210954)
1. Risk Factors of Synchronous Breast and Thyroid Cancer: a Controlled Multicenter Study and Review of the Literature.
Zervoudis S; Iatrakis G; Markja A; Tsatsaris G; Bothou A; von Tempelhoff GF; Balafouta M; Tsikouras P
Mater Sociomed; 2021 Dec; 33(4):298-303. PubMed ID: 35210954
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and survival of patients with metachronous or synchronous double primary malignancies: breast and thyroid cancer.
Zhang L; Wu Y; Liu F; Fu L; Tong Z
Oncotarget; 2016 Aug; 7(32):52450-52459. PubMed ID: 27223440
[TBL] [Abstract][Full Text] [Related]
4. Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer.
Huang NS; Chen XX; Wei WJ; Mo M; Chen JY; Ma B; Yang SW; Xu WB; Wu J; Ji QH; Guo XM; Liu GY; Shao ZM; Wang Y
Cancer Med; 2018 Dec; 7(12):6393-6400. PubMed ID: 30480382
[TBL] [Abstract][Full Text] [Related]
5. High incidence combination of multiple primary malignant tumors of the digestive system.
Yang XB; Zhang LH; Xue JN; Wang YC; Yang X; Zhang N; Liu D; Wang YY; Xun ZY; Li YR; Sun HS; Zhao LJ; Zhao HT
World J Gastroenterol; 2022 Nov; 28(41):5982-5992. PubMed ID: 36405110
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
8. Long-term impact of reproductive factors on cancer risk.
La Vecchia C; Negri E; Franceschi S; Parazzini F
Int J Cancer; 1993 Jan; 53(2):215-9. PubMed ID: 8425757
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Analysis of Patients with Synchronous Primary Breast and Thyroid Carcinoma.
Arer İM; Yabanoğlu H; Kuş M; Akdur A; Avcı T
Eur J Breast Health; 2018 Apr; 14(2):80-84. PubMed ID: 29774315
[TBL] [Abstract][Full Text] [Related]
11. Abortion and the risk of breast cancer: a case-control study in Greece.
Lipworth L; Katsouyanni K; Ekbom A; Michels KB; Trichopoulos D
Int J Cancer; 1995 Apr; 61(2):181-4. PubMed ID: 7705945
[TBL] [Abstract][Full Text] [Related]
12. Dual malignancies in the setting of differentiated thyroid carcinoma: their synchronous or metachronous nature, impact of radioiodine treatment on occurrence of second malignancy and other associated variables.
Gandhi S; Abhyankar A; Basu S
Nucl Med Commun; 2014 Feb; 35(2):205-9. PubMed ID: 24217429
[TBL] [Abstract][Full Text] [Related]
13. [A study on the association between the use of oral contraception and cancer of the breast or cervix: preliminary findings of a French study].
Le MG; Bachelot A; Doyen F; Kramar A
Contracept Fertil Sex (Paris); 1985 Mar; 13(3):553-8. PubMed ID: 12280145
[TBL] [Abstract][Full Text] [Related]
14. [Clinical characteristics and prognostic analysis of double primary breast cancer and thyroid cancer].
Zhai J; Kong XY; Fang Y; Wang J
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1287-1291. PubMed ID: 34915638
[No Abstract] [Full Text] [Related]
15. Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden.
Bakos B; Kiss A; Árvai K; Szili B; Deák-Kocsis B; Tobiás B; Putz Z; Ármós R; Balla B; Kósa J; Dank M; Valkusz Z; Takács I; Tabák Á; Lakatos P
BMC Cancer; 2021 Jun; 21(1):706. PubMed ID: 34130653
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer.
Lei K; He X; Yu L; Ni C; Chen H; Guan D; Sun K; Zou H
PLoS One; 2019; 14(5):e0215948. PubMed ID: 31042767
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen exposure in pregnancy after synchronous breast and thyroid cancer.
Athman Omar AM; Abdel-Bary A; Elsaka RO
Ecancermedicalscience; 2020; 14():1125. PubMed ID: 33209116
[TBL] [Abstract][Full Text] [Related]
18. Nulliparity enhances the risk of second primary malignancy of the breast in a cohort of women treated for thyroid cancer.
Consorti F; Di Tanna G; Milazzo F; Antonaci A
World J Surg Oncol; 2011 Aug; 9():88. PubMed ID: 21835042
[TBL] [Abstract][Full Text] [Related]
19. Possible association between breast thyroid carcinoma: analysis of risk factors.
Del Rio P; Viani L; Bonati E; Marina M; Arcuri MF; Ceresini G
Ann Ital Chir; 2020; 91():173-180. PubMed ID: 32719185
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
